mianserin has been researched along with Behavior Disorders in 16 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mirtazapine is an antidepressant with a mechanism that involves activating serotonin (5-HT1) receptors." | 6.47 | Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature. ( Huang, KC; Lee, WK; Li, TC; Shiah, IS; Sun, CJ; Tzang, RF, 2011) |
| "Mirtazapine is an antidepressant with a mechanism that involves activating serotonin (5-HT1) receptors." | 2.47 | Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature. ( Huang, KC; Lee, WK; Li, TC; Shiah, IS; Sun, CJ; Tzang, RF, 2011) |
| "Emphasis is given to the treatment of depression and how the potential of one pure enantiomer-escitalopram, the S-enantiomer of the selective serotonin reuptake inhibitor citalopram-appears to be fulfilling its preclinical promise in the clinic." | 2.41 | Enantiomers' potential in psychopharmacology--a critical analysis with special emphasis on the antidepressant escitalopram. ( Baumann, P; Eap, CB; Zullino, DF, 2002) |
| "Mirtazapine is an antidepressant that acts by enhancing serotonergic and noradrenergic neurotransmission." | 1.40 | Therapeutic drug monitoring of mirtazapine in a routine outpatient setting in Asian psychiatric patients. ( Jang, JH; Kim, DK; Lee, SY; Myung, W; Yoon, H, 2014) |
| " Our quantitative pharmaco-EEG and clinical trials clearly demonstrated the significant value of quantitative EEG in early screening of psychoactive drugs in order to predict their clinical values and effective dosage ranges." | 1.25 | New drug developments in the Netherlands. "Tetracyclic" psychotropic drugs. ( Dincmen, K; Egilmez, S; Itil, TM; Polvan, N; Sungerbey, K, 1974) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shinozaki, M | 1 |
| Pierce, J | 1 |
| Hayashi, Y | 1 |
| Watanabe, T | 1 |
| Sasaki, T | 1 |
| Komahashi-Sasaki, H | 1 |
| Akiyama, K | 1 |
| Kato, K | 1 |
| Inoue, Y | 1 |
| Tsuchimine, S | 1 |
| Yasui-Furukori, N | 1 |
| Ozeki, Y | 1 |
| Shimoda, K | 1 |
| Myung, W | 1 |
| Jang, JH | 1 |
| Yoon, H | 1 |
| Lee, SY | 1 |
| Kim, DK | 1 |
| Paulzen, M | 1 |
| Gründer, G | 1 |
| Tauber, SC | 1 |
| Veselinovic, T | 1 |
| Hiemke, C | 1 |
| Groppe, SE | 1 |
| Grover, S | 1 |
| Avasthi, A | 1 |
| Tripathi, A | 1 |
| Tanra, AJ | 1 |
| Chee, KY | 1 |
| He, YL | 1 |
| Chiu, HF | 1 |
| Kuga, H | 1 |
| Lee, MS | 1 |
| Chong, MY | 1 |
| Udormatn, P | 1 |
| Kanba, S | 1 |
| Yang, SY | 1 |
| Si, TM | 1 |
| Sim, K | 1 |
| Tan, CH | 1 |
| Shen, WW | 1 |
| Xiang, YT | 1 |
| Sartorius, N | 1 |
| Shinfuku, N | 1 |
| Li, TC | 1 |
| Shiah, IS | 1 |
| Sun, CJ | 1 |
| Tzang, RF | 1 |
| Huang, KC | 1 |
| Lee, WK | 1 |
| Banerjee, S | 1 |
| Hellier, J | 1 |
| Dewey, M | 1 |
| Romeo, R | 1 |
| Ballard, C | 1 |
| Baldwin, R | 1 |
| Bentham, P | 1 |
| Fox, C | 1 |
| Holmes, C | 1 |
| Katona, C | 1 |
| Knapp, M | 1 |
| Lawton, C | 1 |
| Lindesay, J | 1 |
| Livingston, G | 1 |
| McCrae, N | 1 |
| Moniz-Cook, E | 1 |
| Murray, J | 1 |
| Nurock, S | 1 |
| Orrell, M | 1 |
| O'Brien, J | 1 |
| Poppe, M | 1 |
| Thomas, A | 1 |
| Walwyn, R | 1 |
| Wilson, K | 1 |
| Burns, A | 1 |
| Sepehry, AA | 1 |
| Lee, PE | 1 |
| Hsiung, GY | 1 |
| Jacova, C | 1 |
| Baumann, P | 2 |
| Zullino, DF | 1 |
| Eap, CB | 1 |
| Juckel, G | 2 |
| Schüle, C | 1 |
| Pogarell, O | 2 |
| Rupp, D | 1 |
| Laakmann, G | 1 |
| Hegerl, U | 2 |
| Kozyrev, VN | 1 |
| Smulevich, AB | 1 |
| Drobizhev, MIu | 1 |
| Kraeva, GK | 1 |
| Kubrakov, MA | 1 |
| Szegedi, A | 1 |
| Schwertfeger, N | 1 |
| Zullino, D | 1 |
| Mayland, G | 1 |
| Schmidt, LG | 1 |
| Fähndrich, E | 1 |
| Greil, W | 1 |
| Horvath, A | 1 |
| Rüther, E | 1 |
| Engel, R | 1 |
| Hippius, H | 1 |
| Poyurovsky, M | 1 |
| Pashinian, A | 1 |
| Weizman, R | 1 |
| Fuchs, C | 1 |
| Weizman, A | 1 |
| Sterr, A | 1 |
| Padberg, F | 1 |
| Amann, B | 1 |
| Mergl, R | 1 |
| Mulert, C | 1 |
| Itil, TM | 1 |
| Polvan, N | 1 |
| Dincmen, K | 1 |
| Egilmez, S | 1 |
| Sungerbey, K | 1 |
| Hertrich, O | 1 |
4 reviews available for mianserin and Behavior Disorders
| Article | Year |
|---|---|
Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Electroconvulsive Therapy; Fema | 2011 |
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Do | 2011 |
Enantiomers' potential in psychopharmacology--a critical analysis with special emphasis on the antidepressant escitalopram.
Topics: Animals; Antidepressive Agents, Second-Generation; Citalopram; Depression; Fluoxetine; Humans; Menta | 2002 |
Mirtazapine: a review of its clinical efficacy and tolerability.
Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder, Major; Humans; Mental Disorder | 2005 |
2 trials available for mianserin and Behavior Disorders
| Article | Year |
|---|---|
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Do | 2011 |
Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.
Topics: Adult; Akathisia, Drug-Induced; Analysis of Variance; Anti-Anxiety Agents; Antidepressive Agents, Tr | 2006 |
11 other studies available for mianserin and Behavior Disorders
| Article | Year |
|---|---|
8-Hydroxylation and Glucuronidation of Mirtazapine in Japanese Psychiatric Patients: Significance of the Glucuronidation Pathway of 8-Hydroxy-Mirtazapine.
Topics: Age Factors; Alleles; Anti-Anxiety Agents; Asian People; Cytochrome P-450 CYP2D6; Genotype; Glucuron | 2019 |
Therapeutic drug monitoring of mirtazapine in a routine outpatient setting in Asian psychiatric patients.
Topics: Adrenergic alpha-Antagonists; Adult; Age Factors; Aged; Dose-Response Relationship, Drug; Drug Monit | 2014 |
Distribution pattern of mirtazapine and normirtazapine in blood and CSF.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Blood-Brain Barrier; Female; Humans; Male; Mental Dis | 2015 |
Antidepressant Prescription Pattern in the Presence of Medical Co-morbidity: REAP-AD 2013 Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Tricyclic; | 2015 |
Stay the course--is it justified?
Topics: Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Female; Humans; Male; Menta | 2012 |
Epileptiform EEG patterns induced by mirtazapine in both psychiatric patients and healthy volunteers.
Topics: Adult; Antidepressive Agents; Electroencephalography; Epilepsy; Female; Humans; Mental Disorders; Mi | 2003 |
[Psychotropic drugs used in a psychiatric hospital (pharmaco-epidemiologic aspects)].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepin | 2003 |
Prescribing practices in German and Swiss psychiatric university and in non-university hospitals: national differences.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Community Mental Health Centers; Drug Presc | 2005 |
Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.
Topics: Adult; Amitriptyline; Antidepressive Agents; Cerebral Cortex; Citalopram; Cyclohexanols; Electroence | 2006 |
New drug developments in the Netherlands. "Tetracyclic" psychotropic drugs.
Topics: Adjustment Disorders; Anxiety Disorders; Bipolar Disorder; Brain; Clinical Trials as Topic; Dibenzox | 1974 |
[Ataractic treatment in psychiatry and general medicine. Drug overview 10].
Topics: Antipsychotic Agents; Butyrophenones; Humans; Mental Disorders; Mephenesin; Meprobamate; Mianserin; | 1983 |